U-118MGHomo sapiens (Human)Cancer cell line

Also known as: U-118 MG, U-118-MG, U118-MG, U118MG, U118, 118 MG, 118MG

🤖 AI SummaryBased on 16 publications

Quick Overview

Human glioblastoma cell line with known genetic alterations and tumorigenic potential.

Detailed Summary

U-118MG is a human glioblastoma cell line derived from a glioma tumor. It is characterized by specific genetic alterations, including mutations in the TP53, p16, and PTEN genes, which are commonly associated with glioblastoma progression. The cell line exhibits tumorigenic potential, as demonstrated by its ability to form tumors in nude mice. U-118MG is widely used in research to study the molecular mechanisms of glioblastoma, including the role of tumor suppressor genes and signaling pathways involved in tumor growth and progression. Its genetic profile makes it a valuable model for investigating therapeutic strategies targeting these pathways.

Research Applications

Genetic analysis of glioblastomaTumor suppressor gene functionTumorigenicity studiesSignaling pathway investigation

Key Characteristics

TP53 mutationp16 mutationPTEN mutationTumorigenic in nude mice
Generated on 6/15/2025

Basic Information

Database IDCVCL_0633
SpeciesHomo sapiens (Human)
Tissue SourceBrain[UBERON:UBERON_0000955]

Donor Information

Age47
Age CategoryAdult
SexMale
Racecaucasian

Disease Information

DiseaseAstrocytoma
LineageCNS/Brain
SubtypeAstrocytoma
OncoTree CodeASTR

DepMap Information

Source TypeATCC
Source IDACH-000040_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationNone reportedIDH1---PubMed=19435942
MutationSimplePTENc.1026+1G>T (IVS8+1G>T)HomozygousSplice donor mutationfrom parent cell line 1181N1
MutationSimpleTP53p.Arg213Gln (c.638G>A)Homozygous-from parent cell line 1181N1

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X,Y
CSF1PO
11,12
D10S1248
13
D12S391
19,22
D13S317
9
D16S539
12,13
D18S51
13
D19S433
13
D1S1656
11
D21S11
27,32.2
D22S1045
17
D2S1338
23,25
D2S441
11,15
D3S1358
15
D5S818
11
D7S820
9
D8S1179
14,15
FGA
18,23
Penta D
10,13
Penta E
7
TH01
6
TPOX
8
vWA
18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Brain tumors.";

Ali-Osman F.

(In book chapter) Human cell culture. Vol. 2. Cancer cell lines part 2; Masters J.R.W., Palsson B.O. (eds.); pp.167-184; Kluwer Academic Publishers; New York; USA (1999).

Neoplastic human glia cells in culture.";

Ponten J.

(In book chapter) Human tumor cells in vitro; Fogh J. (eds.); pp.175-206; Springer; New York; USA (1975).

Human glioma cell lines.";

Nister M., Westermark B.

(In book chapter) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.17-42; Academic Press; New York; USA (1994).

One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.

Fogh J., Fogh J.M., Orfeo T.

J. Natl. Cancer Inst. 59:221-226(1977).

Human brain tumour cell strains with deficient host-cell reactivation of N-methyl-N'-nitro-N-nitrosoguanidine-damaged adenovirus 5.

Day R.S. 3rd, Ziolkowski C.H.J.

Nature 279:797-799(1979).

Absence of HeLa cell contamination in 169 cell lines derived from human tumors.

Fogh J., Wright W.C., Loveless J.D.

J. Natl. Cancer Inst. 58:209-214(1977).

Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts.

Friedman H.S., Bigner D.D.

Cancer Res. 50:8017-8022(1990).

Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines.

Claesson-Welsh L., Heldin C.-H., Schlessinger J., Westermark B.

Cancer Res. 48:3910-3918(1988).

Human tumor lines for cancer research.";

Fogh J.

Cancer Invest. 4:157-184(1986).

DNA content and chromosomes in permanent cultured cell lines derived from malignant human gliomas.

Bigner S.H., Bjerkvig R., Laerum O.D., Muhlbaier L.H., Bigner D.D.

Anal. Quant. Cytol. Histol. 9:435-444(1987).

The deficient density-dependent growth control of human malignant glioma cells and virus-transformed glia-like cells in culture.

Westermark B.

Int. J. Cancer 12:438-451(1973).

Cytology and growth characteristics of human tumour astrocytes transformed by Rous sarcoma virus.

Macintyre E.H., Grimes R.A., Vatter A.E.

J. Cell Sci. 5:583-602(1969).

Long term culture of normal and neoplastic human glia.";

Ponten J., Macintyre E.H.

Acta Pathol. Microbiol. Scand. 74:465-486(1968).

The ultrastructure of human and murine astrocytes and of human fibroblasts in culture.

Macintyre E.H., Ponten J., Vatter A.E.

Acta Pathol. Microbiol. Scand. A. 80:267-283(1972).

Tumor-specific membrane antigens in established cell lines from gliomas.

Wahlstrom T., Linder E., Saksela E., Westermark B.

Cancer 34:274-279(1974).

Polymorphic enzyme analysis of cultured human tumor cell lines.";

Dracopoli N.C., Fogh J.

J. Natl. Cancer Inst. 70:469-476(1983).

Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas.

Ruoslahti E., Herschman H.R., Eng L.F., Wikstrand C.J.

J. Neuropathol. Exp. Neurol. 40:201-229(1981).

HLA-A, B, C and DR alloantigen expression on forty-six cultured human tumor cell lines.

Pollack M.S., Heagney S.D., Livingston P.O., Fogh J.

J. Natl. Cancer Inst. 66:1003-1012(1981).

Presence of glycogen and growth-related variations in 58 cultured human tumor cell lines of various tissue origins.

Rousset M., Zweibaum A., Fogh J.

Cancer Res. 41:1165-1170(1981).

Functional expression of bombesin receptor in most adult and pediatric human glioblastoma cell lines; role in mitogenesis and in stimulating the mitogen-activated protein kinase pathway.

Sharif T.R., Luo W., Sharif M.

Mol. Cell. Endocrinol. 130:119-130(1997).

Overexpression of protein kinase C epsilon in astroglial brain tumor derived cell lines and primary tumor samples.

Sharif T.R., Sharif M.

Int. J. Oncol. 15:237-243(1999).

Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines.

Van Meir E.G.

Brain Pathol. 9:469-479(1999).

Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts.

Collins V.P.

J. Neuropathol. Exp. Neurol. 58:1170-1183(1999).

Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures.

Wolf E., Gabius H.-J.

J. Cancer Res. Clin. Oncol. 127:375-386(2001).

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.

Fine H.A.

Cancer Cell 9:391-403(2006).

Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug development.

Jones C.

PLoS ONE 4:E5209-E5209(2009).

IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas.

Jones D.T.W., Collins V.P.

Neuro-oncol. 11:341-347(2009).

Check your cultures! A list of cross-contaminated or misidentified cell lines.

Freshney R.I.

Int. J. Cancer 127:1-8(2010).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

DNA fingerprinting of glioma cell lines and considerations on similarity measurements.

Hamou M.-F., Delorenzi M., Hegi M.E.

Neuro-oncol. 14:701-711(2012).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

Origin of the U87MG glioma cell line: good news and bad news.";

Allen M., Bjerke M., Edlund H., Nelander S., Westermark B.

Sci. Transl. Med. 8:354re3.1-354re3.4(2016).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

Quantitative proteomics of the Cancer Cell Line Encyclopedia.";

Sellers W.R., Gygi S.P.

Cell 180:387-402.e16(2020).

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).